(5-(4-(TRIFLUOROMETHYL)-PHENYL)-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO-[E]-[1,4]-DIAZEPIN-3-YL)-CARBAMIC-ACID-TERT.-BUTYLESTER
Compound with spectra: 1 NMR
![(5-(4-(TRIFLUOROMETHYL)-PHENYL)-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO-[E]-[1,4]-DIAZEPIN-3-YL)-CARBAMIC-ACID-TERT.-BUTYLESTER](/api/compound/BiYCQ4NNKoD.png?ph=true&h=300&w=458 "(5-(4-(TRIFLUOROMETHYL)-PHENYL)-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO-[E]-[1,4]-DIAZEPIN-3-YL)-CARBAMIC-ACID-TERT.-BUTYLESTER")
| SpectraBase Compound ID | BiYCQ4NNKoD |
|---|---|
| InChI | InChI=1S/2C21H20F3N3O3/c2*1-20(2,3)30-19(29)27-17-18(28)25-15-7-5-4-6-14(15)16(26-17)12-8-10-13(11-9-12)21(22,23)24/h2*4-11,17H,1-3H3,(H,25,28)(H,27,29) |
| InChIKey | DVKPYHLZDSSVKC-UHFFFAOYSA-N |
| Mol Weight | 838.81 g/mol |
| Molecular Formula | C42H40F6N6O6 |
| Exact Mass | 838.291352 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(5-(4-CHLOROPHENYL)-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO-[E]-[1,4]-DIAZEPIN-3-YL)-CARBAMIC-ACID-TERT.-BUTYLESTER
7-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl acetate
7-Chloro-3-hydroxy-5-(3-hydroxyphenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one
7-chloro-1,3-dihydro-3-[2-(methylthio)ethyl]-5-phenyl-2H-1,4-benzodiazepin-2-one
7-CHLORO-1,3-DIHYDRO-3-ISOBUTYL-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONE
Clorazepate K2 (dep)
7-Chloro-3-isopropyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
tert-butyl N-[(1S)-2-phenyl-1-[(2S)-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-yl]ethyl]carbamate
1H-1,4-Benzodiazepine, 2,3-dihydro-3-(4-methyl-1-piperazinyl)-7-nitro-5-phenyl-
3-Benzylidene-2,3-dihydro-7-methyl-5-phenyl-1H-1,4-benzodiazepin-2-one
| Title | Journal or Book | Year |
|---|---|---|
| New Synthesis of 1,3-Dihydro-1,4-benzodiazepin-2(2H)-ones and 3-Amino-1,3-dihydro-1,4-benzodiazepin-2(2H)-ones: Pd-Catalyzed Cross-Coupling of Imidoyl Chlorides with Organoboronic Acids | The Journal of Organic Chemistry | 2003 |